SunTrust Banks Comments on LHC Group, Inc.’s Q2 2018 Earnings (LHCG)

LHC Group, Inc. (NASDAQ:LHCG) – Equities researchers at SunTrust Banks issued their Q2 2018 earnings per share (EPS) estimates for shares of LHC Group in a report released on Tuesday, April 17th. SunTrust Banks analyst D. Macdonald anticipates that the health services provider will post earnings of $0.82 per share for the quarter. SunTrust Banks also issued estimates for LHC Group’s Q3 2018 earnings at $0.97 EPS, Q4 2018 earnings at $1.12 EPS, FY2018 earnings at $3.52 EPS, Q1 2019 earnings at $0.86 EPS, Q2 2019 earnings at $1.00 EPS, Q3 2019 earnings at $1.07 EPS, Q4 2019 earnings at $1.21 EPS and FY2019 earnings at $4.15 EPS.

How to Become a New Pot Stock Millionaire

LHC Group (NASDAQ:LHCG) last announced its quarterly earnings data on Wednesday, February 28th. The health services provider reported $0.62 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.62. LHC Group had a return on equity of 9.18% and a net margin of 4.67%. The company had revenue of $292.40 million for the quarter, compared to analyst estimates of $280.82 million. During the same quarter in the previous year, the company earned $0.58 EPS. The firm’s revenue for the quarter was up 24.2% compared to the same quarter last year.

LHCG has been the topic of a number of other research reports. BidaskClub raised LHC Group from a “sell” rating to a “hold” rating in a report on Wednesday, April 4th. Zacks Investment Research upgraded shares of LHC Group from a “sell” rating to a “hold” rating in a research report on Wednesday, January 31st. Stephens set a $74.00 price target on shares of LHC Group and gave the company a “buy” rating in a research report on Friday, March 2nd. Craig Hallum lifted their price target on shares of LHC Group from $70.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, April 4th. Finally, Jefferies Group reiterated a “buy” rating and set a $84.00 price target on shares of LHC Group in a research report on Wednesday, April 4th. Two research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $76.80.

Shares of LHCG opened at $73.40 on Thursday. LHC Group has a twelve month low of $51.38 and a twelve month high of $76.14. The company has a market capitalization of $1,324.03, a price-to-earnings ratio of 30.55, a price-to-earnings-growth ratio of 1.17 and a beta of 0.70. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.97 and a current ratio of 1.97.

In other news, COO Donald Dwayne Stelly sold 14,216 shares of LHC Group stock in a transaction that occurred on Tuesday, March 13th. The shares were sold at an average price of $64.00, for a total transaction of $909,824.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 14.80% of the stock is currently owned by company insiders.

Several institutional investors have recently modified their holdings of the stock. American International Group Inc. raised its position in shares of LHC Group by 7.2% during the 3rd quarter. American International Group Inc. now owns 12,533 shares of the health services provider’s stock worth $889,000 after purchasing an additional 840 shares during the last quarter. OppenheimerFunds Inc. raised its position in shares of LHC Group by 10.4% during the 4th quarter. OppenheimerFunds Inc. now owns 11,388 shares of the health services provider’s stock worth $698,000 after purchasing an additional 1,071 shares during the last quarter. Cornercap Investment Counsel Inc. raised its position in shares of LHC Group by 10.2% during the 4th quarter. Cornercap Investment Counsel Inc. now owns 11,845 shares of the health services provider’s stock worth $726,000 after purchasing an additional 1,095 shares during the last quarter. Crossmark Global Holdings Inc. raised its position in shares of LHC Group by 28.0% during the 4th quarter. Crossmark Global Holdings Inc. now owns 5,036 shares of the health services provider’s stock worth $308,000 after purchasing an additional 1,103 shares during the last quarter. Finally, LS Investment Advisors LLC raised its position in shares of LHC Group by 249.5% during the 4th quarter. LS Investment Advisors LLC now owns 2,478 shares of the health services provider’s stock worth $152,000 after purchasing an additional 1,769 shares during the last quarter. Hedge funds and other institutional investors own 89.91% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “SunTrust Banks Comments on LHC Group, Inc.’s Q2 2018 Earnings (LHCG)” was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. & international copyright law. The original version of this article can be viewed at https://ledgergazette.com/2018/04/19/suntrust-banks-comments-on-lhc-group-inc-s-q2-2018-earnings-lhcg.html.

About LHC Group

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply